Literature DB >> 10661401

RAC1/P38 MAPK signaling pathway controls beta1 integrin-induced interleukin-8 production in human natural killer cells.

F Mainiero1, A Soriani, R Strippoli, J Jacobelli, A Gismondi, M Piccoli, L Frati, A Santoni.   

Abstract

The MAP kinase (MAPK) p38 plays a key role in regulating inflammatory responses. Here, we demonstrate that beta1 integrin ligation on human NK cells results in the activation of the p38 MAPK signaling pathway, which is required for integrin-triggered IL-8 production. In addition, we identified some of the upstream events accompanying the beta1 integrin-mediated p38 MAPK activation, namely, the activation of the Rac guanine nucleotide exchange factor (GEF) p95 Vav, the small G protein Rac1, and the cytoplasmic kinases Pak1 and MKK3. Finally, we provide direct evidence that p95 Vav and Rac control the activation of p38 MAPK triggered by beta1 integrins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10661401     DOI: 10.1016/s1074-7613(00)80154-5

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  25 in total

1.  Activity of caffeic acid phenethyl ester in Caenorhabditis elegans.

Authors:  Jeffrey J Coleman; Tomomi Komura; Julia Munro; Michael P Wu; Rakhee R Busanelli; Angela N Koehler; Méryl Thomas; Florence F Wagner; Edward B Holson; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2016-10-14       Impact factor: 3.808

2.  Effect of the disintegrin eristostatin on melanoma-natural killer cell interactions.

Authors:  Stefan Hailey; Elizabeth Adams; Ryan Penn; Alice Wong; Mary Ann McLane
Journal:  Toxicon       Date:  2012-11-09       Impact factor: 3.033

3.  Group I Paks Promote Skeletal Myoblast Differentiation In Vivo and In Vitro.

Authors:  Giselle A Joseph; Min Lu; Maria Radu; Jennifer K Lee; Steven J Burden; Jonathan Chernoff; Robert S Krauss
Journal:  Mol Cell Biol       Date:  2017-02-01       Impact factor: 4.272

4.  Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose- and time-dependent manner.

Authors:  J Lohmeyer; T Nerreter; J Dotterweich; H Einsele; R Seggewiss-Bernhardt
Journal:  Clin Exp Immunol       Date:  2018-05-07       Impact factor: 4.330

Review 5.  Signal transduction during activation and inhibition of natural killer cells.

Authors:  Carsten Watzl; Eric O Long
Journal:  Curr Protoc Immunol       Date:  2010-08

6.  Type XVII collagen regulates lamellipod stability, cell motility, and signaling to Rac1 by targeting bullous pemphigoid antigen 1e to alpha6beta4 integrin.

Authors:  Kevin J Hamill; Susan B Hopkinson; Marcel F Jonkman; Jonathan C R Jones
Journal:  J Biol Chem       Date:  2011-06-03       Impact factor: 5.157

7.  Thrombin induces NF-kappaB activation and IL-8/CXCL8 expression in lung epithelial cells by a Rac1-dependent PI3K/Akt pathway.

Authors:  Chien-Huang Lin; Hui-Wen Cheng; Hon-Ping Ma; Chih-Hsiung Wu; Chuang-Ye Hong; Bing-Chang Chen
Journal:  J Biol Chem       Date:  2011-01-25       Impact factor: 5.157

Review 8.  Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.

Authors:  Benjamin Grabowski; M Alexander Schmidt; Christian Rüter
Journal:  Virulence       Date:  2017-03-15       Impact factor: 5.882

9.  Integrated analysis of mRNA-seq and miRNA-seq for host susceptibilities to influenza A (H7N9) infection in inbred mouse lines.

Authors:  Suying Bao; Lilong Jia; Xueya Zhou; Zhi-Gang Zhang; Hazel Wai Lan Wu; Zhe Yu; Gordon Ng; Yanhui Fan; Dana S M Wong; Shishu Huang; Kelvin Kai Wang To; Kwok-Yung Yuen; Man Lung Yeung; You-Qiang Song
Journal:  Funct Integr Genomics       Date:  2018-03-21       Impact factor: 3.410

10.  Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases.

Authors:  Dezheng Zhao; Sabina Kuhnt-Moore; Huiyan Zeng; Amy Pan; Jack S Wu; Simos Simeonidis; Mary P Moyer; Charalabos Pothoulakis
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.